Literature DB >> 13248800

[Etiological diagnosis of uveitis. I. Clinical and experimental results in man and animal].

R H WITMER.   

Abstract

Entities:  

Keywords:  AQUEOUS HUMOR; UVEITIS

Mesh:

Year:  1955        PMID: 13248800

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Ophthalmol        ISSN: 0376-0200


× No keyword cloud information.
  8 in total

1.  Studies on antibody production in experimental uveitis. 1. Antibody formation in vitro after intraocular injection of typhoid bacilli into the rabbit eye.

Authors:  M I WOLKOWICZ; J W HALLETT; I H LEOPOLD
Journal:  Doc Ophthalmol       Date:  1960       Impact factor: 2.379

2.  [ASO determination in the aqueous humor in uveitis].

Authors:  Z LAFFERS
Journal:  Doc Ophthalmol       Date:  1960       Impact factor: 2.379

3.  [Contribution to acquired ocular toxoplasmosis].

Authors:  F MUELLER
Journal:  Albrecht Von Graefes Arch Ophthalmol       Date:  1959

4.  [Experience with paper electrophoresis of pathological aqueous humor].

Authors:  R WITMER
Journal:  Doc Ophthalmol       Date:  1957       Impact factor: 2.379

5.  [Correlation between enzyme- and antibody activity in experimental uveitis (author's transl)].

Authors:  B Schimmelpfennig
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1974-03-22

Review 6.  Infectious Uveitis in Horses and New Insights in Its Leptospiral Biofilm-Related Pathogenesis.

Authors:  Bettina Wollanke; Hartmut Gerhards; Kerstin Ackermann
Journal:  Microorganisms       Date:  2022-02-07

7.  Analysis of 1840 Equine Intraocular Fluid Samples for the Presence of Anti-Leptospira Antibodies and Leptospiral DNA and the Correlation to Ophthalmologic Findings in Terms of Equine Recurrent Uveitis (ERU)-A Retrospective Study.

Authors:  Tobias Geiger; Hartmut Gerhards; Bogdan Bjelica; Elke Mackenthun; Bettina Wollanke
Journal:  Vet Sci       Date:  2022-08-21

Review 8.  [Ocular toxoplasmosis].

Authors:  U Pleyer; N Torun; O Liesenfeld
Journal:  Ophthalmologe       Date:  2007-07       Impact factor: 1.174

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.